Cargando…
Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials
BACKGROUND: Two Phase III randomized controlled clinical trials were conducted to assess the efficacy, safety, and tolerability of weekly subcutaneous administration of efalizumab for the treatment of psoriasis. Patient reported measures of psoriasis-related functionality and health-related quality...
Autores principales: | Shikiar, Richard, Bresnahan, Brian W, Stone, Stephen P, Thompson, Christine, Koo, John, Revicki, Dennis A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC269993/ https://www.ncbi.nlm.nih.gov/pubmed/14613569 http://dx.doi.org/10.1186/1477-7525-1-53 |
Ejemplares similares
-
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study
por: Shikiar, Richard, et al.
Publicado: (2006) -
The content validity of the PSS in patients with plaque psoriasis
por: Rentz, A. M., et al.
Publicado: (2017) -
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study
por: Revicki, Dennis A, et al.
Publicado: (2008) -
Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis
por: He, Zehui, et al.
Publicado: (2012) -
Content validity and test-retest reliability of patient perception of intensity of urgency scale (PPIUS) for overactive bladder
por: Notte, Sherilyn M, et al.
Publicado: (2012)